XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Concentration Risk [Line Items]          
Rebate receivable $ 46,400   $ 46,400   $ 43,000
Investments in equity-method investees 21,700   21,700   $ 20,100
Proportionate share of earnings in equity-method investees 1,500 $ 1,700 4,065 $ 4,567  
Prepaid expenses and other current assets          
Concentration Risk [Line Items]          
Assets held for sale 9,500   9,500    
Accrued expenses and other current liabilities          
Concentration Risk [Line Items]          
Liabilities held for sale $ 2,000   $ 2,000    
Revenue from Contract with Customer Benchmark | Company's Largest Payer          
Concentration Risk [Line Items]          
Concentration ​risk 14.00% 16.00% 15.00% 16.00%  
Revenue from Contract with Customer Benchmark | Governmental Healthcare Programs          
Concentration Risk [Line Items]          
Concentration ​risk 12.00% 12.00% 12.00% 12.00%  
Accounts Receivable | Governmental Healthcare Programs          
Concentration Risk [Line Items]          
Concentration ​risk     11.00%   11.00%
Cost of Goods and Service, Product and Service Benchmark | Medical Supply Vendors          
Concentration Risk [Line Items]          
Concentration ​risk 74.00% 65.00% 73.00% 65.00%